BioMarin Pharmaceutical Inc. - Laporan Laba Rugi (TTM)

BioMarin Pharmaceutical Inc.
CH ˙ BRSE ˙ US09061G1013
Laporan Laba Rugi (TTM)

Laporan Laba Rugi BioMarin Pharmaceutical Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,863 1,860 1,844 1,917 1,849 1,846 1,880 1,912 2,008 2,096 2,173 2,235 2,311 2,419 2,472 2,588 2,753 2,854 2,950 3,064
Change (%) -0.12 -0.86 3.91 -3.55 -0.12 1.81 1.71 5.05 4.37 3.68 2.83 3.40 4.70 2.17 4.72 6.35 3.67 3.37 3.84
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,138 1,152 1,168 1,176 1,101 1,099 1,108 1,101 1,114 503 1,011 1,189 694 532 555 561 971 580 560 558
Change (%) 1.24 1.32 0.69 -6.33 -0.18 0.81 -0.62 1.15 -54.85 100.94 17.68 -41.64 -23.35 4.29 1.13 72.99 -40.23 -3.43 -0.51
% of Revenue 61.11 61.94 63.31 61.34 59.57 59.54 58.96 57.61 55.47 24.00 46.51 53.23 30.04 21.99 22.45 21.68 35.27 20.33 18.99 18.20
Gross Operating Profit 724 708 677 741 747 747 771 810 894 1,593 1,162 1,045 1,616 1,887 1,917 2,027 1,782 2,274 2,390 2,506
Change (%) -2.27 -4.42 9.48 0.86 -0.05 3.27 5.05 10.35 78.14 -27.04 -10.08 54.66 16.75 1.57 5.76 -12.10 27.59 5.11 4.86
% of Revenue 38.89 38.06 36.69 38.66 40.43 40.46 41.04 42.39 44.53 76.00 53.49 46.77 69.96 78.01 77.55 78.32 64.73 79.67 81.01 81.80
SG&A 730 738 725 733 737 759 780 792 826 823 847 857 856 892 907 964 1,002 913 893 863
Change (%) 1.04 -1.76 1.21 0.53 2.99 2.67 1.63 4.23 -0.31 2.94 1.09 -0.12 4.30 1.67 6.27 3.91 -8.86 -2.17 -3.44
% of Revenue 39.19 39.65 39.29 38.27 39.89 41.13 41.48 41.45 41.12 39.28 39.00 38.34 37.03 36.89 36.71 37.25 36.40 32.00 30.28 28.16
R&D 650 152 541 747 747 747 391 747 747 747
Change (%) -76.60 38.16 0.00 0.00 -47.62 91.02 0.00 0.00
% of Revenue 30.99 7.00 23.39 30.87 30.21 28.85 14.21 26.18 25.33 24.39
OpEx 1,931 1,952 1,954 1,971 1,900 1,921 1,950 1,956 2,003 2,041 2,073 2,109 2,153 2,233 2,270 2,332 2,413 2,284 2,235 2,192
Change (%) 1.08 0.11 0.86 -3.58 1.06 1.53 0.30 2.39 1.94 1.55 1.74 2.08 3.74 1.63 2.73 3.48 -5.34 -2.15 -1.93
% of Revenue 103.68 104.93 105.96 102.84 102.81 104.03 103.74 102.31 99.71 97.39 95.40 94.38 93.18 92.32 91.83 90.08 87.65 80.03 75.75 71.54
Operating Income -69 -92 -110 -54 -52 -74 -70 -44 6 55 100 126 158 186 202 257 340 570 715 872
Change (%) 33.90 19.75 -50.45 -4.69 43.19 -5.35 -37.19 -113.02 850.26 82.98 25.49 25.52 17.88 8.64 27.19 32.47 67.62 25.51 21.86
% of Revenue -3.68 -4.93 -5.96 -2.84 -2.81 -4.03 -3.74 -2.31 0.29 2.61 4.60 5.62 6.82 7.68 8.17 9.92 12.35 19.97 24.25 28.46
Interest Expense -31 -29 -26 -22 -16 -15 -15 -15 -16 -16 -16 -16 -15 -17 -17 -17 -16 -13 -12 -11
Change (%) -6.93 -10.61 -16.15 -26.07 -5.56 0.01 0.27 5.26 -1.36 -0.64 -0.66 -5.71 16.63 -0.90 -1.05 -4.77 -21.75 -5.40 -7.47
% of Revenue -1.69 -1.58 -1.42 -1.15 -0.88 -0.83 -0.82 -0.80 -0.81 -0.76 -0.73 -0.71 -0.64 -0.72 -0.70 -0.66 -0.59 -0.44 -0.41 -0.36
Net Income 852 854 795 837 16 -64 39 54 84 142 72 100 147 168 205 257 322 427 524 657
Change (%) 0.24 -6.90 5.30 -98.10 -502.59 -161.40 37.42 55.19 68.70 -49.41 39.62 47.03 14.03 22.55 24.89 25.61 32.45 22.73 25.46
% of Revenue 45.74 45.90 43.11 43.68 0.86 -3.47 2.09 2.83 4.18 6.75 3.30 4.47 6.36 6.93 8.31 9.91 11.71 14.96 17.76 21.45

Source: Capital IQ

Other Listings
MX:BMRN
IT:1BMRN € 49.88
GB:0HNC
US:BMRN US$ 57.77
DE:BM8 € 48.39
AT:BMRN
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista